Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tango Therapeutics Inc
(NQ:
TNGX
)
3.920
+0.290 (+7.99%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,277,733
Open
3.590
Bid (Size)
3.720 (1)
Ask (Size)
3.920 (214)
Prev. Close
3.630
Today's Range
3.430 - 3.950
52wk Range
2.700 - 13.01
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Analyst Landscape: 5 Takes On Tango Therapeutics
November 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 06, 2024
Via
Benzinga
Performance
YTD
-60.72%
-60.72%
1 Month
-37.48%
-37.48%
3 Month
-66.12%
-66.12%
6 Month
-43.27%
-43.27%
1 Year
-47.94%
-47.94%
More News
Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 06, 2024
Via
Benzinga
Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
November 06, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program
November 06, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Analyst Scoreboard: 4 Ratings For Tango Therapeutics
September 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 10, 2024
Via
Benzinga
Tango Therapeutics to Participate in Upcoming Investor Conferences
August 28, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Analyst Expectations For Tango Therapeutics's Future
August 08, 2024
Via
Benzinga
Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
August 07, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Expert Outlook: Tango Therapeutics Through The Eyes Of 6 Analysts
July 09, 2024
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For Tango Therapeutics
May 24, 2024
Via
Benzinga
Recap: Tango Therapeutics Q4 Earnings
March 18, 2024
Via
Benzinga
Tango Therapeutics: Q3 Earnings Insights
November 08, 2023
Via
Benzinga
Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity
May 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 23, 2024
Via
Benzinga
Tango Therapeutics Announces Discontinuation of TNG348 Program
May 23, 2024
From
Tango Therapeutics
Via
Business Wire
TNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
May 08, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
TNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q4 2023
March 18, 2024
Via
InvestorPlace
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
March 18, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tango Therapeutics to Participate in Upcoming Investor Conferences
March 06, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Pancreatic Cancer Treatments Poised for Major Advances in 2024
February 07, 2024
Via
FinancialNewsMedia
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.